Torthaí cuardaigh - Laura Van't Veer

Beachtaigh na torthaí
  1. 1
    Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays

    Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays de réir Kathy S. Albain, Soonmyung Paik, Laura van’t Veer

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    The MINDACT trial: The first prospective clinical validation of a genomic tool

    The MINDACT trial: The first prospective clinical validation of a genomic tool de réir Fátima Cardoso, Martine Piccart, Laura Van't Veer, Emiel J. Rutgers

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary

    Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary de réir John Bridgewater, Ryan K. van Laar, Arno Floore, Laura van’t Veer

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity

    Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity de réir Denise M. Wolf, Marc E. Lenburg, Christina Yau, Aaron Boudreau, Laura van ‘t Veer

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma

    Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma de réir Patti Curl, Igor Vujic, Laura van ‘t Veer, Susana Ortiz‐Urda, James G. Kahn

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein.

    TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. de réir Guus Hateboer, H. T. Marc Timmers, AK Rustgi, Marc Billaud, Laura van ‘t Veer, René Bernards

    Foilsithe / Cruthaithe 1993
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    E2F-5, a New E2F Family Member That Interacts with p130 In Vivo

    E2F-5, a New E2F Family Member That Interacts with p130 In Vivo de réir E. Marielle Hijmans, P. Mathijs Voorhoeve, Roderick L. Beijersbergen, Laura van ‘t Veer, René Bernards

    Foilsithe / Cruthaithe 1995
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability

    Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability de réir Josien C.C. Scheepens, Laura van ‘t Veer, Laura J. Esserman, Jeffrey Belkora, Rita A. Mukhtar

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance

    Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance de réir Pavel Stejskal, Hani Goodarzi, Josef Srovnal, Marián Hajdúch, Laura van ‘t Veer, Mark Jesus M. Magbanua

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian polycomb complex.

    Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian polycomb complex. de réir Mark J. Alkema, Marieke Bronk, Els Verhoeven, Arie P. Otte, Laura van ‘t Veer, A Berns, Maarten van Lohuizen

    Foilsithe / Cruthaithe 1997
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature

    Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature de réir Michael Knauer, Fátima Cardoso, Jelle Wesseling, Philippe L. Bédard, Sabine C. Linn, Emiel J. Rutgers, Laura van ‘t Veer

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis

    Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis de réir Alexandra J. van den Broek, Marjanka K. Schmidt, Laura van ‘t Veer, Rob A.�E.�M. Tollenaar, Flora E. van Leeuwen

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Comparison of prognostic gene expression signatures for breast cancer

    Comparison of prognostic gene expression signatures for breast cancer de réir Benjamin Haibe‐Kains, Christine Desmedt, Fanny Piette, Marc Buyse, Fátima Cardoso, Laura van’t Veer, Martine Piccart, Gianluca Bontempi, Christos Sotiriou

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Expression profiling predicts outcome in breast cancer

    Expression profiling predicts outcome in breast cancer de réir Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver, Yudong D. He, Augustinus A. M. Hart, René Bernards, Stephen Friend

    Foilsithe / Cruthaithe 2002
    Faigh an téacs iomlán Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer

    Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer de réir Rob Michalides, Alexander Griekspoor, Astrid Balkenende, Desirée Verwoerd, Lennert Janssen, Kees Jalink, Arno Floore, Arno Velds, Laura van 't Veer, Jacques Neefjes

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    N-ras mutations in human cutaneous melanoma from sun-exposed body sites.

    N-ras mutations in human cutaneous melanoma from sun-exposed body sites. de réir Laura van ‘t Veer, Boudewijn Burgering, Rogier Versteeg, A J Boot, D. J. Ruiter, Susanne Osanto, Peter I. Schrier, Johannes L. Bos

    Foilsithe / Cruthaithe 1989
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    A protocol for building and evaluating predictors of disease state based on microarray data

    A protocol for building and evaluating predictors of disease state based on microarray data de réir Lodewyk F.A. Wessels, Marcel J. T. Reinders, A.A.M. Hart, Cor J. Veenman, H. Dai, Yudong D. He, Laura van ‘t Veer

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients

    Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients de réir James M. Ford, Sophie Adams, Taylor Sittler, Jeroen van den Akker, Salina Chan, Ofri Leitner, Lauren Ryan, Elad Gil, Laura van ’t Veer

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    A combined oncogenic pathway signature of<i>BRAF</i>,<i>KRAS</i>and<i>PI3KCA</i>mutation improves colorectal cancer classification and cetuximab treatment prediction

    A combined oncogenic pathway signature of<i>BRAF</i>,<i>KRAS</i>and<i>PI3KCA</i>mutation improves colorectal cancer classification and cetuximab treatment prediction de réir Sun Tian, Iris Simón, Vı́ctor Moreno, Paul Roepman, Josep Tabernero, Mireille H.J. Snel, Laura van’t Veer, Ramón Salazar, René Bernards, Gabriel Capellà

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Additional prognostic value of the 70-gene signature (MammaPrint®) among breast cancer patients with 4–9 positive lymph nodes

    Additional prognostic value of the 70-gene signature (MammaPrint®) among breast cancer patients with 4–9 positive lymph nodes de réir Mahasti Saghatchian, Stella Mook, Giancarlo Pruneri, Giuseppe Viale, Annuska M. Glas, Sylvie Guérin, Fátima Cardoso, Martine Piccart, Thomas Tursz, Suzette Delaloge, Laura van’t Veer

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: